US EditionDatar Cancer Genetics Unveils Advanced Blood Test for MRD
Summary by Clinical Lab Products
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
Datar Cancer Genetics Unveils Advanced Blood Test for MRD
Summary: Datar Cancer Genetics introduced a highly sensitive blood test that combines tumor-agnostic NGS and tumor-informed dd-PCR to detect MRD and enable early intervention in solid organ cancers. Takeaways: Early Cancer Recurrence Detection: Target-MRD identifies molecular residual disease (MRD) at the molecular level, allowing oncologists to intervene before cancer relapse becomes clinically detectable. Dual-Technology Approach: The test co…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
